HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,256 | +5.9% | 7,991 | 0.0% | 0.11% | +14.3% |
| Q2 2023 | $288,235 | +43.6% | 7,991 | +52.1% | 0.10% | +32.4% |
| Q1 2023 | $200,688 | -34.6% | 5,255 | -32.4% | 0.07% | -45.6% |
| Q3 2022 | $307,000 | +12.5% | 7,769 | +25.3% | 0.14% | +20.4% |
| Q2 2022 | $273,000 | +33.8% | 6,199 | +21.4% | 0.11% | +63.8% |
| Q1 2022 | $204,000 | -11.3% | 5,108 | -10.6% | 0.07% | 0.0% |
| Q4 2021 | $230,000 | -0.9% | 5,712 | 0.0% | 0.07% | -5.5% |
| Q3 2021 | $232,000 | -10.4% | 5,712 | 0.0% | 0.07% | -8.8% |
| Q2 2021 | $259,000 | +8.8% | 5,712 | 0.0% | 0.08% | +6.7% |
| Q1 2021 | $238,000 | – | 5,712 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |